BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol. 2000;7:87-97. [PMID: 10761786 DOI: 10.1007/s10434-000-0087-9] [Cited by in Crossref: 374] [Cited by in F6Publishing: 280] [Article Influence: 17.8] [Reference Citation Analysis]
Number Citing Articles
1 Zitelli JA. Sentinel lymph node biopsy: an alternate view. Dermatol Surg 2008;34:544-9; discussion 549. [PMID: 18261108 DOI: 10.1111/j.1524-4725.2007.34099.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
2 Chakera AH, Lock-Andersen J, Hesse U, Nürnberg BM, Juhl BR, Stokholm KH, Drzewiecki KT, Hesse B. One-day or two-day procedure for sentinel node biopsy in melanoma? Eur J Nucl Med Mol Imaging 2009;36:928-37. [PMID: 19153733 DOI: 10.1007/s00259-008-1036-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
3 Ryan WR, Heaton CM, Wang SJ. Elective regional lymphadenectomy for advanced auricular squamous cell carcinoma. World J Otorhinolaryngol 2013; 3(1): 16-21 [DOI: 10.5319/wjo.v3.i1.16] [Reference Citation Analysis]
4 Ribero S, Quaglino P, Osella-abate S, Sanlorenzo M, Senetta R, Macrì L, Savoia P, Macripò G, Sapino A, Bernengo M. Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes: Prognostic relevance of MLBD in trunk melanoma. Journal of the European Academy of Dermatology and Venereology 2013;27:1132-7. [DOI: 10.1111/j.1468-3083.2012.04677.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
5 Lasithiotakis KG, Leiter U, Eigentler T, Breuninger H, Metzler G, Meier F, Garbe C. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed? Cancer 2007;109:1174-82. [PMID: 17265520 DOI: 10.1002/cncr.22511] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
6 Lee JH, Essner R, Torisu-Itakura H, Wanek L, Wang H, Morton DL. Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma. J Clin Oncol 2004;22:3677-84. [PMID: 15365064 DOI: 10.1200/JCO.2004.01.012] [Cited by in Crossref: 120] [Cited by in F6Publishing: 20] [Article Influence: 7.1] [Reference Citation Analysis]
7 Mancera N, Smalley KS, Margo CE. Melanoma of the eyelid and periocular skin: Histopathologic classification and molecular pathology. Survey of Ophthalmology 2019;64:272-88. [DOI: 10.1016/j.survophthal.2018.12.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
8 Francken AB, Accortt NA, Shaw HM, Wiener M, Soong S, Hoekstra HJ, Thompson JF. Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous Melanoma. Ann Surg Oncol 2008;15:1476-84. [DOI: 10.1245/s10434-007-9717-9] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
9 Uren RF, Thompson JF, Howman-giles R. Sentinel lymph node biopsy in patients with melanoma and breast cancer. Intern Med J 2001;31:547-53. [DOI: 10.1046/j.1445-5994.2001.01282.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
10 van Akkooi A, Verhoef C, van Geel A, Kliffen M, Eggermont A, de Wilt J. Sentinel node biopsy for clear cell sarcoma. European Journal of Surgical Oncology (EJSO) 2006;32:996-9. [DOI: 10.1016/j.ejso.2006.03.044] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
11 Caracò C, Marone U, Botti G, Celentano E, Lastoria S, Mozzillo N. Age as predictor in patients with cutaneous melanoma submitted to sentinel lymph node biopsy. Eur J Surg Oncol 2006;32:970-3. [PMID: 16996239 DOI: 10.1016/j.ejso.2006.07.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
12 Wright BE, Scheri RP, Ye X, Faries MB, Turner RR, Essner R, Morton DL. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg 2008;143:892-9; discussion 899-900. [PMID: 18794428 DOI: 10.1001/archsurg.143.9.892] [Cited by in Crossref: 94] [Cited by in F6Publishing: 82] [Article Influence: 7.2] [Reference Citation Analysis]
13 Gershenwald JE, Ross MI. Is sentinel-node biopsy superior to nodal observation in melanoma? Nat Rev Clin Oncol 2007;4:278-9. [DOI: 10.1038/ncponc0791] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
14 Salti GI, Das Gupta TK. Predicting residual lymph node basin disease in melanoma patients with sentinel lymph node metastases. The American Journal of Surgery 2003;186:98-101. [DOI: 10.1016/s0002-9610(03)00169-7] [Cited by in Crossref: 35] [Cited by in F6Publishing: 4] [Article Influence: 1.9] [Reference Citation Analysis]
15 Johnson TM, Sondak VK, Bichakjian CK, Sabel MS. The role of sentinel lymph node biopsy for melanoma: evidence assessment. J Am Acad Dermatol. 2006;54:19-27. [PMID: 16384752 DOI: 10.1016/j.jaad.2005.09.029] [Cited by in Crossref: 49] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
16 Bichakjian CK, Halpern AC, Johnson TM, Foote Hood A, Grichnik JM, Swetter SM, Tsao H, Barbosa VH, Chuang TY, Duvic M, Ho VC, Sober AJ, Beutner KR, Bhushan R, Smith Begolka W; American Academy of Dermatology. Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol 2011;65:1032-47. [PMID: 21868127 DOI: 10.1016/j.jaad.2011.04.031] [Cited by in Crossref: 251] [Cited by in F6Publishing: 188] [Article Influence: 25.1] [Reference Citation Analysis]
17 Natarajan S, Taneja C, Cady B. Evolution of Lymphadenectomy in Surgical Oncology. Surgical Oncology Clinics of North America 2005;14:447-59. [DOI: 10.1016/j.soc.2005.04.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
18 Leong SPL. Selective Sentinel Lymph Node Mapping and Dissection for Malignant Melanoma. In: Leong SPL, editor. Atlas of Selective Sentinel Lymphadenectomy for Melanoma, Breast Cancer and Colon Cancer. Boston: Kluwer Academic Publishers; 2002. pp. 39-64. [DOI: 10.1007/0-306-47822-6_3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Singer M, Mutch MG. Anal melanoma. Clin Colon Rectal Surg 2006;19:78-87. [PMID: 20011314 DOI: 10.1055/s-2006-942348] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
20 Voit CA, van Akkooi AC, Schäfer-Hesterberg G, Schoengen A, Schmitz PI, Sterry W, Eggermont AM. Rotterdam Criteria for sentinel node (SN) tumor burden and the accuracy of ultrasound (US)-guided fine-needle aspiration cytology (FNAC): can US-guided FNAC replace SN staging in patients with melanoma? J Clin Oncol 2009;27:4994-5000. [PMID: 19738131 DOI: 10.1200/JCO.2008.19.0033] [Cited by in Crossref: 79] [Cited by in F6Publishing: 18] [Article Influence: 6.6] [Reference Citation Analysis]
21 Martin RC, Shannon KF, Quinn MJ, Saw RP, Spillane AJ, Stretch JR, Colman MH, Gao K, Thompson JF. The management of cervical lymph nodes in patients with cutaneous melanoma. Ann Surg Oncol 2012;19:3926-32. [PMID: 22669449 DOI: 10.1245/s10434-012-2374-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
22 Bartlett EK, Karakousis GC. Current staging and prognostic factors in melanoma. Surg Oncol Clin N Am 2015;24:215-27. [PMID: 25769707 DOI: 10.1016/j.soc.2014.12.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
23 Nowecki ZI, Rutkowski P, Michej W. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Ann Surg Oncol 2008;15:2223-34. [PMID: 18506535 DOI: 10.1245/s10434-008-9965-3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
24 Hyams DM, Cook RW, Buzaid AC. Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers. J Surg Oncol 2019;119:175-86. [PMID: 30548543 DOI: 10.1002/jso.25319] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
25 van Akkooi A, Bouwhuis M, van Geel A, Hoedemaker R, Verhoef C, Grunhagen D, Schmitz P, Eggermont A, de Wilt J. Morbidity and prognosis after therapeutic lymph node dissections for malignant melanoma. European Journal of Surgical Oncology (EJSO) 2007;33:102-8. [DOI: 10.1016/j.ejso.2006.10.032] [Cited by in Crossref: 89] [Cited by in F6Publishing: 77] [Article Influence: 6.4] [Reference Citation Analysis]
26 Morton DL. Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 2012;29:699-706. [PMID: 22729520 DOI: 10.1007/s10585-012-9503-3] [Cited by in Crossref: 102] [Cited by in F6Publishing: 70] [Article Influence: 11.3] [Reference Citation Analysis]
27 Testori A, Soteldo J, Powell B, Sales F, Borgognoni L, Rutkowski P, Lejeune F, van Leeuwen P, Eggermont A. Surgical management of melanoma: an EORTC Melanoma Group survey. Ecancermedicalscience 2013;7:294. [PMID: 23589724 DOI: 10.3332/ecancer.2013.294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
28 Rueth NM, Groth SS, Tuttle TM, Virnig BA, Al-Refaie WB, Habermann EB. Conditional survival after surgical treatment of melanoma: an analysis of the Surveillance, Epidemiology, and End Results database. Ann Surg Oncol 2010;17:1662-8. [PMID: 20165985 DOI: 10.1245/s10434-010-0965-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
29 Taneja C, Cady B. Decreasing role of lymphatic system surgery in surgical oncology. J Surg Oncol 2005;89:61-6. [DOI: 10.1002/jso.20198] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
30 Ruiter DJ, Spatz A, van den Oord JJ, Cook MG. Pathologic staging of melanoma. Seminars in Oncology 2002;29:370-81. [DOI: 10.1053/sonc.2002.34116] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
31 Jakub JW, Reintgen DS, Shivers S, Pendas S. Regional node dissection for melanoma: techniques and indication. Surg Oncol Clin N Am 2007;16:247-61. [PMID: 17336247 DOI: 10.1016/j.soc.2006.10.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
32 Russell-jones R, Acland K. Sentinel node biopsy in the management of malignant melanoma: SLN biopsy in management of MM. Clinical and Experimental Dermatology 2001;26:463-8. [DOI: 10.1046/j.1365-2230.2001.00868.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
33 Karakousis G, Gimotty PA, Bartlett EK, Sim MS, Neuwirth MG, Fraker D, Czerniecki BJ, Faries MB. Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis. Ann Surg Oncol 2017;24:952-9. [PMID: 27807729 DOI: 10.1245/s10434-016-5646-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
34 Ross MI, Gershenwald JE. How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)? Ann Surg Oncol 2008;15:670-3. [PMID: 18228101 DOI: 10.1245/s10434-008-9828-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
35 El-sayed IH, Singer MI, Civantos F. Sentinel lymph node biopsy in head and neck cancer. Otolaryngologic Clinics of North America 2005;38:145-60. [DOI: 10.1016/j.otc.2004.09.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
36 Han D, Thomas DC, Zager JS, Pockaj B, White RL, Leong SP. Clinical utilities and biological characteristics of melanoma sentinel lymph nodes. World J Clin Oncol 2016; 7(2): 174-188 [PMID: 27081640 DOI: 10.5306/wjco.v7.i2.174] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
37 Pagès C, Rochaix P, al Saati T, Valmary-Degano S, Boulinguez S, Launay F, Carle P, Lauwers F, Payoux P, Le Guellec S. KBA.62: a useful marker for primary and metastatic melanomas. Hum Pathol. 2008;39:1136-1142. [PMID: 18495211 DOI: 10.1016/j.humpath.2007.12.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
38 Deperalta DK, Hoang MP, Tanabe KK. Approaches to Regional Nodes in Patients With Melanoma. JCO 2014;32:881-5. [DOI: 10.1200/jco.2013.52.3571] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Mcmasters KM, Swetter SM. Current management of melanoma: Benefits of surgical staging and adjuvant therapy. J Surg Oncol 2003;82:209-16. [DOI: 10.1002/jso.10216] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
40 Swetter SM, Tsao H, Bichakjian CK, Curiel-Lewandrowski C, Elder DE, Gershenwald JE, Guild V, Grant-Kels JM, Halpern AC, Johnson TM, Sober AJ, Thompson JA, Wisco OJ, Wyatt S, Hu S, Lamina T. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol 2019;80:208-50. [PMID: 30392755 DOI: 10.1016/j.jaad.2018.08.055] [Cited by in Crossref: 169] [Cited by in F6Publishing: 126] [Article Influence: 56.3] [Reference Citation Analysis]
41 Bottoni U, Clerico R, Paolino G, Ambrifi M, Corsetti P, Calvieri S. Predictors and survival in patients with melanoma brain metastases. Med Oncol 2013;30:466. [PMID: 23377924 DOI: 10.1007/s12032-013-0466-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
42 Gomez-rivera F, Santillan A, Mcmurphey AB, Paraskevopoulos G, Roberts DB, Prieto VG, Myers JN. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: Recurrence and survival study. Head Neck 2008;30:1284-94. [DOI: 10.1002/hed.20875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
43 Zervos EE, Burak WE Jr. Lymphatic mapping in solid neoplasms: state of the art. Cancer Control 2002;9:189-202. [PMID: 12060817 DOI: 10.1177/107327480200900302] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
44 Easson AM, Rotstein LE, Mccready DR. Lymph node assessment in melanoma. J Surg Oncol 2009;99:176-85. [DOI: 10.1002/jso.21202] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
45 Thomas JM. Time for comprehensive reporting of MSLT-I. The Lancet Oncology 2006;7:9-11. [DOI: 10.1016/s1470-2045(05)70518-0] [Cited by in Crossref: 12] [Article Influence: 0.8] [Reference Citation Analysis]
46 Chang JW, Huang YL, Chang YY, Lo YF, Ho TY, Huang YT, Chen HW, Wu CE. Sentinel Lymph Node Biopsy Was Associated With Favorable Survival Outcomes For Patients With Clinically Node-Negative Asian Melanoma. Cancer Manag Res 2019;11:9655-64. [PMID: 31814762 DOI: 10.2147/CMAR.S227837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
47 Yang JC, Sherry RM, Rosenberg SA. Melanoma: Why is sentinel lymph node biopsy 'standard of care' for melanoma? Nat Rev Clin Oncol 2014;11:245-6. [PMID: 24732941 DOI: 10.1038/nrclinonc.2014.65] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
48 Rawson RV, Scolyer RA. From Breslow to BRAF and immunotherapy: evolving concepts in melanoma pathogenesis and disease progression and their implications for changing management over the last 50 years. Hum Pathol 2020;95:149-60. [PMID: 31704364 DOI: 10.1016/j.humpath.2019.09.017] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Bonnen MD, Ballo MT, Myers JN, Garden AS, Diaz EM, Gershenwald JE, Morrison WH, Lee JE, Oswald MJ, Ross MI, Ang KK. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer 2004;100:383-9. [DOI: 10.1002/cncr.11921] [Cited by in Crossref: 61] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
50 Leilabadi SN, Chen A, Tsai S, Soundararajan V, Silberman H, Wong AK. Update and Review on the Surgical Management of Primary Cutaneous Melanoma. Healthcare (Basel) 2014;2:234-49. [PMID: 27429273 DOI: 10.3390/healthcare2020234] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
51 Jaber JJ, Clark JI, Muzaffar K, Ruggiero FP, Feustel PJ, Frett MJ, Zender CA. Evolving treatment strategies in thin cutaneous head and neck melanoma: 1 institution's experience. Head Neck 2011;33:7-12. [DOI: 10.1002/hed.21403] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
52 Martel P, Garrido I, Ferron G, Gangloff D, Chevreau C, Maisongrosse V, Zerdoud S, Simon C, Chapman T. Les mélanomes du tronc ont-ils un pronostic individualisable? À propos d'une série de 77 cas. Bulletin du Cancer 2010;97:901-7. [DOI: 10.1684/bdc.2010.1094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
53 Spanknebel K, Temple L, Hiotis S, Yeh A, Coit DG. Randomized Clinical Trials in Melanoma. Surgical Oncology Clinics of North America 2002;11:23-52. [DOI: 10.1016/s1055-3207(03)00074-7] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
54 Pawlik TM, Ross MI, Johnson MM, Schacherer CW, Mcclain DM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE. Predictors and Natural History of In-Transit Melanoma After Sentinel Lymphadenectomy. Ann Surg Oncol 2005;12:587-96. [DOI: 10.1245/aso.2005.05.025] [Cited by in Crossref: 157] [Cited by in F6Publishing: 39] [Article Influence: 9.8] [Reference Citation Analysis]
55 Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF; for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017;67:472-92. [PMID: 29028110 DOI: 10.3322/caac.21409] [Cited by in Crossref: 865] [Cited by in F6Publishing: 729] [Article Influence: 216.3] [Reference Citation Analysis]
56 Eggermont AM, Gore M. Randomized adjuvant therapy trials in melanoma: surgical and systemic. Semin Oncol 2007;34:509-15. [PMID: 18083374 DOI: 10.1053/j.seminoncol.2007.09.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
57 Coit D. Sentinel lymph node biopsy for melanoma: a plea to let the data speak. Ann Surg Oncol. 2014;21:3359-3361. [PMID: 25059791 DOI: 10.1245/s10434-014-3947-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
58 Caracò C, Chiofalo M, Niro J, Ascierto P, Botti G, Lastoria S, Mozzillo N. Sentinel Lymph Node Biopsy to Stage Patients with Cutaneous Melanoma at the National Cancer Institute of Naples. Results from 240 Sentinel Node Biopsies. Tumori 2002;88:S12-3. [DOI: 10.1177/030089160208800324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
59 Gershenwald JE, Scolyer RA, Hess KR, Thompson JF, Long GV, Ross MI, Lazar AJ, Atkins MB, Balch CM, Barnhill RL, Bilimoria KY, Brierley JD, Buzaid AC, Byrd DR, Chapman PB, Cochran AJ, Coit DG, Eggermont AM, Elder DE, Faries MB, Flaherty KT, Garbe C, Gardner JM, Gimotty PA, Halpern AC, Haydu LE, Johnson T, Kirkwood JM, Lee AWM, Mcarthur GA, Mihm MC, Prieto VG, Sober AJ, Wahl RL, Wong SL, Sondak VK. Melanoma of the Skin. In: Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. Cham: Springer International Publishing; 2017. pp. 563-86. [DOI: 10.1007/978-3-319-40618-3_47] [Cited by in Crossref: 54] [Cited by in F6Publishing: 25] [Article Influence: 10.8] [Reference Citation Analysis]
60 Fujisawa Y, Otsuka F. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients. Melanoma Research 2012;22:362-7. [DOI: 10.1097/cmr.0b013e328355e558] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
61 Leong SP. Selective sentinel lymphadenectomy for malignant melanoma. Surg Clin North Am. 2003;83:157-85, vii. [PMID: 12691454 DOI: 10.1016/s0039-6109(02)00206-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
62 Bartlett EK, Meise C, Bansal N, Fischer JP, Low DW, Czerniecki BJ, Roses RE, Fraker DL, Kelz RR, Karakousis GC. Sartorius transposition during inguinal lymphadenectomy for melanoma. Journal of Surgical Research 2013;184:209-15. [DOI: 10.1016/j.jss.2013.04.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
63 Coit DG. In-Transit Recurrence After Sentinel Lymph NodeBiopsy in Melanoma: Primum Non Nocere. Ann Surg Oncol 2005;12:575-8. [DOI: 10.1245/aso.2005.03.903] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
64 Newlands C, Gurney B. Management of regional metastatic disease in head and neck cutaneous malignancy. 2. Cutaneous malignant melanoma. Br J Oral Maxillofac Surg 2014;52:301-7. [PMID: 24565440 DOI: 10.1016/j.bjoms.2014.01.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
65 Braunstein LZ, Chen M, Dosoretz DE, Salenius SA, Katin MJ, Nanda A, D'amico AV. Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk. Clinical Genitourinary Cancer 2015;13:555-61. [DOI: 10.1016/j.clgc.2015.04.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
66 van Akkooi AC, de Wilt JH, Verhoef C, Graveland WJ, van Geel AN, Kliffen M, Eggermont AM. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma. Eur J Cancer 2006;42:372-80. [PMID: 16403622 DOI: 10.1016/j.ejca.2005.10.023] [Cited by in Crossref: 81] [Cited by in F6Publishing: 70] [Article Influence: 5.4] [Reference Citation Analysis]
67 Bello DM, Faries MB. The Landmark Series: MSLT-1, MSLT-2 and DeCOG (Management of Lymph Nodes). Ann Surg Oncol 2020;27:15-21. [PMID: 31535299 DOI: 10.1245/s10434-019-07830-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
68 Chu PY, Chen YF, Li CY, Yang JS, King YA, Chiu YJ, Ma H. Factors influencing locoregional recurrence and distant metastasis in Asian patients with cutaneous melanoma after surgery: A retrospective analysis in a tertiary hospital in Taiwan. J Chin Med Assoc 2021. [PMID: 34282077 DOI: 10.1097/JCMA.0000000000000586] [Reference Citation Analysis]
69 Alzaraa A, Sharma N. Primary cutaneous melanoma of the breast: A case report. Cases J 2008;1:212. [PMID: 18834539 DOI: 10.1186/1757-1626-1-212] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
70 Chan AD, Morton DL. Sentinel Node Detection in Malignant Melanoma. In: Schlag PM, Veronesi U, editors. Lymphatic Metastasis and Sentinel Lymphonodectomy. Berlin: Springer Berlin Heidelberg; 2000. pp. 161-77. [DOI: 10.1007/978-3-642-57151-0_14] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
71 Mattsson J, Bergkvist L, Abdiu A, Aili low JF, Naredi P, Ullberg K, Garpered U, Håkansson A, Ingvar C. Sentinel node biopsy in malignant melanoma: Swedish experiences 1997–2005. Acta Oncologica 2009;47:1519-25. [DOI: 10.1080/02841860701785533] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
72 Garbe C, Eigentler TK, Keilholz U, Hauschild A, Kirkwood JM. Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist. 2011;16:5-24. [PMID: 21212434 DOI: 10.1634/theoncologist.2010-0190] [Cited by in Crossref: 342] [Cited by in F6Publishing: 306] [Article Influence: 34.2] [Reference Citation Analysis]
73 Pasquali S, Mocellin S, Campana LG, Bonandini E, Montesco MC, Tregnaghi A, Del Fiore P, Nitti D, Rossi CR. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: Personal Experience and Literature Meta-Analysis. Cancer 2010;116:1201-9. [DOI: 10.1002/cncr.24852] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
74 Bartlett EK, Gupta M, Datta J, Gimotty PA, Guerry D, Xu X, Elder DE, Czerniecki BJ, Fraker DL, Karakousis GC. Prognosis of patients with melanoma and microsatellitosis undergoing sentinel lymph node biopsy. Ann Surg Oncol 2014;21:1016-23. [PMID: 24258854 DOI: 10.1245/s10434-013-3388-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.9] [Reference Citation Analysis]
75 Crystal J, Faries MB. Sentinel Lymph Node Biopsy: Indications and Technique. Surg Oncol Clin N Am 2020;29:401-14. [PMID: 32482316 DOI: 10.1016/j.soc.2020.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
76 Aloia TA, Gershenwald JE, Andtbacka RH, Johnson MM, Schacherer CW, Ng CS, Cormier JN, Lee JE, Ross MI, Mansfield PF. Utility of Computed Tomography and Magnetic Resonance Imaging Staging Before Completion Lymphadenectomy in Patients With Sentinel Lymph Node–Positive Melanoma. JCO 2006;24:2858-65. [DOI: 10.1200/jco.2006.05.6176] [Cited by in Crossref: 61] [Cited by in F6Publishing: 8] [Article Influence: 4.1] [Reference Citation Analysis]
77 Faries MB. Completing the Dissection in Melanoma: Increasing Decision Precision. Ann Surg Oncol 2018;25:585-7. [PMID: 29302819 DOI: 10.1245/s10434-017-6330-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
78 Morton D, Cochran A. The case for lymphatic mapping and sentinel lymphadenectomy in the management of primary melanoma. Br J Dermatol 2004;151:308-19. [DOI: 10.1111/j.1365-2133.2004.06133.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
79 Reintgen DS. Regional Nodal Surgery for Melanoma Impacts Recurrence Rates and Survival. Ann Surg Oncol 2000;7:80-1. [DOI: 10.1007/s10434-000-0080-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
80 Solomon J, Mavinkurve S, Cox D, Summers RM. Computer-assisted detection of subcutaneous melanomas. Academic Radiology 2004;11:678-85. [DOI: 10.1016/j.acra.2004.01.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
81 Cebollero A, Puértolas T, Pajares I, Calera L, Antón A. Comparative safety of BRAF and MEK inhibitors (vemurafenib, dabrafenib and trametinib) in first-line therapy for BRAF-mutated metastatic melanoma. Mol Clin Oncol 2016;5:458-62. [PMID: 27699043 DOI: 10.3892/mco.2016.978] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
82 Zhang Y, Liu C, Wang Z, Zhu G, Zhang Y, Xu Y, Xu X. Sentinel lymph node biopsy in head and neck cutaneous melanomas: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e24284. [PMID: 33592872 DOI: 10.1097/MD.0000000000024284] [Reference Citation Analysis]
83 Allan CP, Hayes AJ, Thomas JM. ILIOINGUINAL LYMPH NODE DISSECTION FOR PALPABLE METASTATIC MELANOMA TO THE GROIN. ANZ Journal of Surgery 2008;78:982-6. [DOI: 10.1111/j.1445-2197.2008.04716.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
84 Ariyan CE, Coit DG. Clinical aspects of sentinel lymph node biopsy in melanoma. Seminars in Diagnostic Pathology 2008;25:86-94. [DOI: 10.1053/j.semdp.2008.04.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
85 Yang JC, Sherry RM. MSLT-I—response of clinical trial investigators. Nat Rev Clin Oncol 2014;11:680-680. [DOI: 10.1038/nrclinonc.2014.65-c2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 Balch CM, Buzaid AC, Soong S, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A, Kirkwood JM, Mcmasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. JCO 2001;19:3635-48. [DOI: 10.1200/jco.2001.19.16.3635] [Cited by in Crossref: 1958] [Cited by in F6Publishing: 374] [Article Influence: 97.9] [Reference Citation Analysis]
87 Möhrle M, Breuninger H. Sentinel-Node-Biopsie: Welche Aussagen sind gesichert? Hautarzt 2005;56:441-7. [DOI: 10.1007/s00105-005-0927-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
88 Machet L, Vaillant L, Lorette G. [Follow-up of excision of cutaneous melanoma: sentinel node biopsy, lymph node ultrasound or clinical surveillance alone?]. Ann Dermatol Venereol 2005;132:941-4. [PMID: 16446633 DOI: 10.1016/s0151-9638(05)79553-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
89 Rutkowski P, Nowecki ZI, Nasierowska-Guttmejer A, Ruka W. Lymph node status and survival in cutaneous malignant melanoma--sentinel lymph node biopsy impact. Eur J Surg Oncol 2003;29:611-8. [PMID: 12943629 DOI: 10.1016/s0748-7983(03)00118-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
90 Reeves ME, Delgado R, Busam KJ, Brady MS, Coit DG. Prediction of Nonsentinel Lymph Node Status in Melanoma. Ann Surg Oncol 2003;10:27-31. [DOI: 10.1245/aso.2003.03.020] [Cited by in Crossref: 105] [Cited by in F6Publishing: 16] [Article Influence: 5.8] [Reference Citation Analysis]
91 Hohnheiser AM, Gefeller O, Göhl J, Schuler G, Hohenberger W, Merkel S. Malignant melanoma of the skin: long-term follow-up and time to first recurrence. World J Surg 2011;35:580-9. [PMID: 21125274 DOI: 10.1007/s00268-010-0859-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
92 van Poll D, Thompson JF, Colman MH, Mckinnon JG, Saw RPM, Stretch JR, Scolyer RA, Uren RF. A Sentinel Node Biopsy Does Not Increase the Incidence of In-Transit Metastasis in Patients With Primary Cutaneous Melanoma. Ann Surg Oncol 2005;12:597-608. [DOI: 10.1245/aso.2005.08.012] [Cited by in Crossref: 58] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
93 Macripò G, Quaglino P, Caliendo V, Ronco AM, Soltani S, Giacone E, Pau S, Fierro MT, Bernengo MG. Sentinel lymph node dissection in stage I/II melanoma patients: surgical management and clinical follow-up study: . Melanoma Research 2004;14:S9-S12. [DOI: 10.1097/00008390-200404000-00016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
94 Medalie NS, Ackerman AB. Sentinel Lymph Node Biopsy Has No Benefit for Patients with Primary Cutaneous Melanoma Metastatic to a Lymph Node: An Assertion Based on Comprehensive, Critical Analysis: Part I. The American Journal of Dermatopathology 2003;25:399-417. [DOI: 10.1097/00000372-200310000-00006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
95 van den Broek FJ, Sloots PC, de Waard JD, Roumen RM. Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years’ experience in two regional training hospitals in the Netherlands. Int J Clin Oncol 2013;18:428-34. [DOI: 10.1007/s10147-012-0399-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
96 Angeles CV, Wong SL, Karakousis G. The Landmark Series: Randomized Trials Examining Surgical Margins for Cutaneous Melanoma. Ann Surg Oncol 2020;27:3-12. [DOI: 10.1245/s10434-019-07866-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
97 Algazi AP, Soon CW, Daud AI. Treatment of cutaneous melanoma: current approaches and future prospects. Cancer Manag Res. 2010;2:197-211. [PMID: 21188111 DOI: 10.2147/cmar.s6073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
98 Balch CM, Soong SJ, Smith T, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Desmond R; Investigators from the Intergroup Melanoma Surgical Trial. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol 2001;8:101-8. [PMID: 11258773 DOI: 10.1007/s10434-001-0101-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 40] [Article Influence: 0.5] [Reference Citation Analysis]
99 Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Puleo CA, Coventry BJ. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599-609. [PMID: 24521106 DOI: 10.1056/nejmoa1310460] [Cited by in Crossref: 850] [Cited by in F6Publishing: 206] [Article Influence: 121.4] [Reference Citation Analysis]
100 Pidhorecky I, Lee RJ, Proulx G, Kollmorgen DR, Jia C, Driscoll DL, Kraybill WG, Gibbs JF. Risk Factors for Nodal Recurrence After Lymphadenectomy for Melanoma. Ann Surg Oncol 2001;8:109-15. [DOI: 10.1007/s10434-001-0109-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
101 Testori AAE, Blankenstein SA, van Akkooi ACJ. Primary Melanoma: from History to Actual Debates. Curr Oncol Rep 2019;21:112. [PMID: 31858280 DOI: 10.1007/s11912-019-0843-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Balch CM, Soong SJ. Predicting outcomes in metastatic melanoma. J Clin Oncol 2008;26:168-9. [PMID: 18182655 DOI: 10.1200/JCO.2007.13.8123] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
103 Jimenez RE, Panageas K, Busam KJ, Brady MS. Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma. J Clin Oncol 2005;23:518-24. [PMID: 15659497 DOI: 10.1200/JCO.2005.00.075] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
104 Bilimoria KY, Balch CM, Bentrem DJ, Talamonti MS, Ko CY, Lange JR, Winchester DP, Wayne JD. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol 2008;15:1566-76. [PMID: 18414952 DOI: 10.1245/s10434-008-9885-2] [Cited by in Crossref: 104] [Cited by in F6Publishing: 86] [Article Influence: 8.0] [Reference Citation Analysis]
105 Agarwala SS. Intermediate- and high-risk melanoma. Curr Treat Options in Oncol 2002;3:205-17. [DOI: 10.1007/s11864-002-0010-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
106 Tsutsumida A, Furukawa H, Yamamoto Y, Sugihara T. Treatment strategy for cutaneous malignant melanoma. Int J Clin Oncol 2005;10:311-7. [PMID: 16247657 DOI: 10.1007/s10147-005-0522-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
107 Averbook BJ, Fu P, Rao JS, Mansour EG. A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging. Surgery. 2002;132:589-602; discussion 602-604. [PMID: 12407342 DOI: 10.1067/msy.2002.127546] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
108 Gorantla VC, Kirkwood JM. State of melanoma: an historic overview of a field in transition. Hematol Oncol Clin North Am 2014;28:415-35. [PMID: 24880939 DOI: 10.1016/j.hoc.2014.02.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
109 Vuylsteke R, van Leeuwen P, Muller MS, Gietema H, Kragt D, Meijer S. Clinical Outcome of Stage I/II Melanoma Patients After Selective Sentinel Lymph Node Dissection: Long-Term Follow-Up Results. JCO 2003;21:1057-65. [DOI: 10.1200/jco.2003.07.170] [Cited by in Crossref: 127] [Cited by in F6Publishing: 9] [Article Influence: 7.1] [Reference Citation Analysis]
110 Rødgaard JC, Kramer S, Stolle LB. Sentinel node biopsy (SNB) in malignant melanoma as same day procedure vs delayed procedure: clinical and economic outcome. Journal of Plastic Surgery and Hand Surgery 2013;48:265-9. [DOI: 10.3109/2000656x.2013.870910] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
111 Sober AJ, Chuang T, Duvic M, Farmer ER, Grichnik JM, Halpern AC, Ho V, Holloway V, Hood AF, Johnson TM, Lowery BJ. Guidelines of care for primary cutaneous melanoma. Journal of the American Academy of Dermatology 2001;45:579-86. [DOI: 10.1067/mjd.2001.117044] [Cited by in Crossref: 144] [Cited by in F6Publishing: 89] [Article Influence: 7.2] [Reference Citation Analysis]
112 Doting M, Hoekstra H, Plukker J, Piers D, Jager P, Tiebosch A, Vermey A, Schraffordt Koops H. Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. European Journal of Surgical Oncology (EJSO) 2002;28:673-8. [DOI: 10.1053/ejso.2002.1297] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 3.5] [Reference Citation Analysis]
113 Piepkorn M, Barnhill RL. Prognostic Factors in Cutaneous Malignant Melanoma. In: Barnhill RL, Piepkorn M, Busam KJ, editors. Pathology of Melanocytic Nevi and Malignant Melanoma. New York: Springer; 2004. pp. 372-94. [DOI: 10.1007/978-0-387-21619-5_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
114 Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma: 2010 update Part II. J Am Acad Dermatol 2010;62:737-48;quiz 749-50. [PMID: 20398811 DOI: 10.1016/j.jaad.2009.11.696] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
115 Iorio ML, Ter Louw RP, Kauffman CL, Davison SP. Evidence-Based Medicine: Facial Skin Malignancy. Plastic and Reconstructive Surgery 2013;132:1631-43. [DOI: 10.1097/prs.0b013e3182a8085f] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
116 Chakera AH, Drzewiecki KT, Eigtved A, Juhl BR. Sentinel node biopsy for melanoma: a study of 241 patients: . Melanoma Research 2004;14:521-6. [DOI: 10.1097/00008390-200412000-00013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
117 Cheng D, McNicoll CF, Kirgan D, Jones MS, Rivera MR, Doyle GM, De Guzman MD, Baynosa J, St Hill CR. The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma. Am J Surg 2021;221:737-40. [PMID: 32354604 DOI: 10.1016/j.amjsurg.2020.03.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 de Rosa N, Lyman GH, Silbermins D, Valsecchi ME, Pruitt SK, Tyler DM, Lee WT. Sentinel Node Biopsy for Head and Neck Melanoma: A Systematic Review. Otolaryngol Head Neck Surg 2011;145:375-82. [DOI: 10.1177/0194599811408554] [Cited by in Crossref: 82] [Cited by in F6Publishing: 69] [Article Influence: 8.2] [Reference Citation Analysis]
119 Ross MI, Gershenwald JE. Evidence-based treatment of early-stage melanoma: Evidence-Based Treatment of Early-Stage Melanoma. J Surg Oncol 2011;104:341-53. [DOI: 10.1002/jso.21962] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
120 Ho T, Byrne PJ. Evaluation and Initial Management of the Patient with Facial Skin Cancer. Facial Plastic Surgery Clinics of North America 2009;17:301-7. [DOI: 10.1016/j.fsc.2009.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
121 Chuang T, Brashear R, Wagner JD, Farmer ER. Principles of evidence-based management using stage I-II melanoma as a model: Principles of evidence-based management. International Journal of Dermatology 2002;41:721-8. [DOI: 10.1046/j.1365-4362.2002.01504.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
122 Bullard KM, Tuttle TM, Rothenberger DA, Madoff RD, Baxter NN, Finne CO, Spencer MP. Surgical therapy for anorectal melanoma. J Am Coll Surg. 2003;196:206-211. [PMID: 12595048 DOI: 10.1016/s1072-7515(02)01538-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 31] [Article Influence: 4.6] [Reference Citation Analysis]
123 Gilmore DM, Khullar OV, Gioux S, Stockdale A, Frangioni JV, Colson YL, Russell SE. Effective low-dose escalation of indocyanine green for near-infrared fluorescent sentinel lymph node mapping in melanoma. Ann Surg Oncol. 2013;20:2357-2363. [PMID: 23440551 DOI: 10.1245/s10434-013-2905-x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 7.1] [Reference Citation Analysis]
124 Tas F, Kurul S, Camlica H, Topuz E. Malignant Melanoma in Turkey: A Single Institution's Experience on 475 Cases. Japanese Journal of Clinical Oncology 2006;36:794-9. [DOI: 10.1093/jjco/hyl114] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
125 Le TT, Pitman KT. Prognostic factors in melanoma outcome and survival. Facial Plastic Surgery Clinics of North America 2003;11:33-41. [DOI: 10.1016/s1064-7406(02)00058-5] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
126 Livingstone E, Windemuth-kieselbach C, Eigentler TK, Rompel R, Trefzer U, Nashan D, Rotterdam S, Ugurel S, Schadendorf D. A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up. European Journal of Cancer 2011;47:1977-89. [DOI: 10.1016/j.ejca.2011.04.029] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
127 Kimura T, Sugaya M, Oka T, Blauvelt A, Okochi H, Sato S. Lymphatic dysfunction attenuates tumor immunity through impaired antigen presentation. Oncotarget 2015;6:18081-93. [PMID: 26098776 DOI: 10.18632/oncotarget.4018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
128 McHugh JB, Su L, Griffith KA, Schwartz JL, Wong SL, Cimmino V, Chang AE, Johnson TM, Sabel MS. Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol 2006;13:1216-23. [PMID: 16952026 DOI: 10.1245/s10434-006-9014-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
129 Rousseau DL, Gershenwald JE. The new staging system for cutaneous melanoma in the era of lymphatic mapping. Seminars in Oncology 2004;31:415-25. [DOI: 10.1053/j.seminoncol.2004.03.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
130 Gutzmer R, Al Ghazal M, Geerlings H, Kapp A. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Br J Dermatol 2005;153:1137-41. [DOI: 10.1111/j.1365-2133.2005.06941.x] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
131 van Akkooi AC, Nowecki ZI, Voit C, Schäfer-Hesterberg G, Michej W, de Wilt JH, Rutkowski P, Verhoef C, Eggermont AM. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg. 2008;248:949-955. [PMID: 19092339 DOI: 10.1097/sla.0b013e31818fefe0] [Cited by in Crossref: 188] [Cited by in F6Publishing: 37] [Article Influence: 15.7] [Reference Citation Analysis]
132 Perrott RE, Glass L, Reintgen DS, Fenske NA. Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. Journal of the American Academy of Dermatology 2003;49:567-88. [DOI: 10.1067/s0190-9622(03)02136-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 1] [Article Influence: 3.1] [Reference Citation Analysis]
133 Pawlik TM, Ross MI, Shaw HM, Thompson JF, Gershenwald JE. Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark. European Journal of Surgical Oncology (EJSO) 2005;31:323-4. [DOI: 10.1016/j.ejso.2004.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
134 Keung EZ, Gershenwald JE. Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma. J Natl Cancer Inst 2020;112:875-85. [PMID: 32061122 DOI: 10.1093/jnci/djaa012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
135 Mosquera C, Vora HS, Vohra N, Fitzgerald TL. Population-Based Analysis of Completion Lymphadenectomy in Intermediate-Thickness Melanoma. Ann Surg Oncol 2017;24:127-34. [PMID: 27464609 DOI: 10.1245/s10434-016-5460-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
136 Durham AB, Wong SL. Sentinel lymph node biopsy in melanoma: controversies and current guidelines. Future Oncology 2014;10:429-42. [DOI: 10.2217/fon.13.245] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
137 Ramirez R, Ivan D, Prieto VG, Hayek B, Diwan H, Savar A, Esmaeli B. Cutaneous Melanoma Metastatic to the Eyelid and Periocular Skin. Ophthalmic Plastic & Reconstructive Surgery 2010;26:88-94. [DOI: 10.1097/iop.0b013e3181b8e06f] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
138 Leblanc RE, Barton DT, Li Z, Angeles CV, Ernstoff MS, Bagley E, Wimmer D, Wong SL, Barth RJ, Shirai K, Yan S. Small and Isolated Immunohistochemistry-positive Cells in Melanoma Sentinel Lymph Nodes Are Associated With Disease-specific and Recurrence-free Survival Comparable to that of Sentinel Lymph Nodes Negative for Melanoma. American Journal of Surgical Pathology 2019;43:755-65. [DOI: 10.1097/pas.0000000000001229] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
139 Rogers GS, Braun SM. Prognostic factors. Dermatologic Clinics 2002;20:647-58. [DOI: 10.1016/s0733-8635(02)00027-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
140 Nenu I, Tudor D, Filip AG, Baldea I. Current position of TNF-α in melanomagenesis. Tumor Biol 2015;36:6589-602. [DOI: 10.1007/s13277-015-3639-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
141 Kachare SD, Brinkley J, Wong JH, Vohra NA, Zervos EE, Fitzgerald TL. The influence of sentinel lymph node biopsy on survival for intermediate-thickness melanoma. Ann Surg Oncol. 2014;21:3377-3385. [PMID: 25063010 DOI: 10.1245/s10434-014-3954-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
142 Morton DL, Hoon DS, Cochran AJ, Turner RR, Essner R, Takeuchi H, Wanek LA, Glass E, Foshag LJ, Hsueh EC. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238:538-549; discussion 549-550. [PMID: 14530725 DOI: 10.1097/01.sla.0000086543.45557.cb] [Cited by in Crossref: 94] [Cited by in F6Publishing: 131] [Article Influence: 5.2] [Reference Citation Analysis]
143 Deshmane V, Kalloli M, Chikaraddi S, Keerthi B, Krishnappa R. Predictive factors for loco regional recurrence and distant metastasis following primary surgical treatment of cutaneous melanoma. Indian J Dermatol 2014;59:241-6. [PMID: 24891653 DOI: 10.4103/0019-5154.131383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
144 Cloyd JM, Wapnir IL, Read BM, Swetter S, Greco RS. Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma. J Surg Oncol. 2014;110:888-892. [PMID: 25124992 DOI: 10.1002/jso.23745] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
145 White RR, Stanley WE, Johnson JL, Tyler DS, Seigler HF. Long-term survival in 2,505 patients with melanoma with regional lymph node metastasis. Ann Surg 2002;235:879-87. [PMID: 12035046 DOI: 10.1097/00000658-200206000-00017] [Cited by in Crossref: 96] [Cited by in F6Publishing: 81] [Article Influence: 5.1] [Reference Citation Analysis]
146 Fayne RA, Macedo FI, Rodgers SE, Möller MG. Evolving management of positive regional lymph nodes in melanoma: Past, present and future directions. Oncol Rev 2019;13:433. [PMID: 31857858 DOI: 10.4081/oncol.2019.433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
147 Algazi AP, Soon CW, Daud AI. Treatment of cutaneous melanoma: current approaches and future prospects. Cancer Manag Res 2010;2:197-211. [PMID: 21188111 DOI: 10.2147/CMR.S6073] [Cited by in Crossref: 1] [Cited by in F6Publishing: 19] [Article Influence: 0.1] [Reference Citation Analysis]
148 Luongo V, Pirozzi G, Caraco C, Errico S, de Angelis F, Celentano E, Paino F, Chiofalo M, Luongo M, Mozzillo N, Lombardi M. HLA allele frequency and clinical outcome in Italian patients with cutaneous melanoma. Tissue Antigens 2004;64:84-7. [DOI: 10.1111/j.0001-2815.2004.00250.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
149 Nielsen KR, Grossjohann HS, Hansen CP, Nielsen MB. Use of contrast-enhanced ultrasound imaging to detect the first draining lymph node (FDLN) in a swine model: correlation of imaging findings with the distance from the injection site to the FDLN. J Ultrasound Med 2008;27:1203-9. [PMID: 18645079 DOI: 10.7863/jum.2008.27.8.1203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
150 Ettl T, Irga S, Müller S, Rohrmeier C, Reichert TE, Schreml S, Gosau M. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas. J Craniomaxillofac Surg 2014;42:e252-8. [PMID: 24216129 DOI: 10.1016/j.jcms.2013.09.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
151 Chudnovsky Y, Khavari PA, Adams AE. Melanoma genetics and the development of rational therapeutics. J Clin Invest 2005;115:813-24. [PMID: 15841168 DOI: 10.1172/JCI24808] [Cited by in Crossref: 112] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
152 Zettersten E, Sagebiel RW, Miller JR, Tallapureddy S, Leong SPL, Kashani-sabet M. Prognostic factors in patients with thick cutaneous melanoma (> 4 mm). Cancer 2002;94:1049-56. [DOI: 10.1002/cncr.10326] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
153 Gervasoni JE, Taneja C, Chung MA, Cady B. Biologic and clinical significance of lymphadenectomy. Surg Clin North Am. 2000;80:1631-1673. [PMID: 11140865 DOI: 10.1016/s0039-6109(05)70253-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
154 Rigual NR, Popat SR, Jayaprakash V, Jaggernauth W, Wong M. Cutaneous head and neck melanoma: the old and the new. Expert Rev Anticancer Ther 2008;8:403-12. [PMID: 18366288 DOI: 10.1586/14737140.8.3.403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
155 Koshenkov VP, Broucek J, Kaufman HL. Surgical Management of Melanoma. Cancer Treat Res 2016;167:149-79. [PMID: 26601862 DOI: 10.1007/978-3-319-22539-5_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
156 Cady B. Sentinel lymph node procedure in squamous cell carcinoma of the vulva. J Clin Oncol 2000;18:2795-7. [PMID: 10920125 DOI: 10.1200/JCO.2000.18.15.2795] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
157 Dunki-jacobs EM, Callender GG, Mcmasters KM. Current management of melanoma. Current Problems in Surgery 2013;50:351-82. [DOI: 10.1067/j.cpsurg.2013.04.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
158 Faries MB, Morton DL. Surgery and sentinel lymph node biopsy. Semin Oncol 2007;34:498-508. [PMID: 18083373 DOI: 10.1053/j.seminoncol.2007.09.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
159 Balch CM. Microscopic satellites around a primary melanoma: another piece of the puzzle in melanoma staging. Ann Surg Oncol 2009;16:1092-4. [PMID: 19247717 DOI: 10.1245/s10434-009-0353-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
160 Ryan M, Crow J, Kahmke R, Fisher SR, Su Z, Lee WT. FoxP3 and indoleamine 2,3-dioxygenase immunoreactivity in sentinel nodes from melanoma patients. Am J Otolaryngol 2014;35:689-94. [PMID: 25212103 DOI: 10.1016/j.amjoto.2014.08.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
161 Crowson AN, Magro CM, Mihm MC. Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol 2006;19 Suppl 2:S71-87. [PMID: 16446717 DOI: 10.1038/modpathol.3800517] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
162 Stadelmann WK. The Role of Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Staging and Treatment of Melanoma. Clinics in Plastic Surgery 2010;37:79-99. [DOI: 10.1016/j.cps.2009.08.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
163 Moroi Y. Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data. Int J Clin Oncol 2009;14:485-9. [PMID: 19967482 DOI: 10.1007/s10147-009-0942-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
164 Payette MJ, Katz M 3rd, Grant-Kels JM. Melanoma prognostic factors found in the dermatopathology report. Clin Dermatol 2009;27:53-74. [PMID: 19095154 DOI: 10.1016/j.clindermatol.2008.09.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
165 van Akkooi AC, Verhoef C, Eggermont AM. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas. Nat Rev Clin Oncol 2010;7:446-54. [PMID: 20567244 DOI: 10.1038/nrclinonc.2010.100] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
166 Meier F, Will S, Ellwanger U, Schlagenhauff B, Schittek B, Rassner G, Garbe C. Metastatic pathways and time courses in the orderly progression of cutaneous melanoma. Br J Dermatol 2002;147:62-70. [PMID: 12100186 DOI: 10.1046/j.1365-2133.2002.04867.x] [Cited by in Crossref: 209] [Cited by in F6Publishing: 161] [Article Influence: 11.0] [Reference Citation Analysis]
167 Faries MB, Ariyan S. Current surgical treatment in melanoma. Curr Probl Cancer 2011;35:173-84. [PMID: 21911181 DOI: 10.1016/j.currproblcancer.2011.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
168 Masoud SJ, Perone JA, Farrow NE, Mosca PJ, Tyler DS, Beasley GM. Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma. Curr Treat Options Oncol 2018;19:55. [PMID: 30232648 DOI: 10.1007/s11864-018-0575-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
169 Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL, Laman SD, Kottschade LA, Maples WJ, Pittelkow MR, Pulido JS, Cameron JD, Creagan ET; Melanoma Study Group of Mayo Clinic Cancer Center. Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc 2007;82:490-513. [PMID: 17418079 DOI: 10.4065/82.4.490] [Cited by in Crossref: 101] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
170 Leong SP. Role of selective sentinel lymph node dissection in head and neck melanoma. J Surg Oncol. 2011;104:361-368. [PMID: 21858830 DOI: 10.1002/jso.21964] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
171 Beasley GM, Zager JS, Thompson JF. The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma. Ann Surg Oncol 2020;27:35-42. [PMID: 31471842 DOI: 10.1245/s10434-019-07760-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
172 Lee DY, Lau BJ, Huynh KT, Flaherty DC, Lee JH, Stern SL, O'Day SJ, Foshag LJ, Faries MB. Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma. J Am Coll Surg 2016;223:9-18. [PMID: 27236435 DOI: 10.1016/j.jamcollsurg.2016.01.045] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
173 Dickson PV, Gershenwald JE. Staging and prognosis of cutaneous melanoma. Surg Oncol Clin N Am 2011;20:1-17. [PMID: 21111956 DOI: 10.1016/j.soc.2010.09.007] [Cited by in Crossref: 95] [Cited by in F6Publishing: 81] [Article Influence: 9.5] [Reference Citation Analysis]
174 Kaikaris V, Samsanavičius D, Kęstutis Maslauskas, Rimdeika R, Valiukevičienė S, Makštienė J, Pundzius J. Measurement of melanoma thickness--comparison of two methods: ultrasound versus morphology. J Plast Reconstr Aesthet Surg 2011;64:796-802. [PMID: 21123126 DOI: 10.1016/j.bjps.2010.10.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
175 Vazquez Vde L, Silva TB, Vieira Mde A, de Oliveira AT, Lisboa MV, de Andrade DA, Fregnani JH, Carneseca EC. Melanoma characteristics in Brazil: demographics, treatment, and survival analysis. BMC Res Notes 2015;8:4. [PMID: 25592837 DOI: 10.1186/s13104-015-0972-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
176 American Joint Committee on Cancer. Melanoma of the Skin. AJCC Cancer Staging Manual. New York: Springer; 2010. pp. 325-44. [DOI: 10.1007/978-0-387-88441-7_31] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
177 Gimotty PA, Yoon F, Hammond R, Rosenbaum P, Guerry D. Therapeutic effect of sentinel lymph node biopsy in melanoma remains an open question. J Clin Oncol 2009;27:4236-8. [PMID: 19667261 DOI: 10.1200/JCO.2009.23.4518] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
178 Oliver DE, Patel KR, Parker D, Delman KA, Lawson DH, Kudchadkar RR, Khan MK. The emerging role of radiotherapy for desmoplastic melanoma and implications for future research. Melanoma Research 2015;25:95-102. [DOI: 10.1097/cmr.0000000000000139] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
179 Estourgie S, Nieweg O, Kroon B. The sentinel node procedure in patients with melanoma. European Journal of Surgical Oncology (EJSO) 2004;30:713-4. [DOI: 10.1016/j.ejso.2004.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
180 de Wilt JH, van Akkooi AC, Verhoef C, Eggermont AM. Detection of melanoma micrometastases in sentinel nodes – The cons. Surgical Oncology 2008;17:175-81. [DOI: 10.1016/j.suronc.2008.06.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
181 Thomas J, Clark M. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. European Journal of Surgical Oncology (EJSO) 2004;30:686-91. [DOI: 10.1016/j.ejso.2004.04.004] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 4.6] [Reference Citation Analysis]
182 Francken AB, Accortt NA, Shaw HM, Colman MH, Wiener M, Soong SJ, Hoekstra HJ, Thompson JF. Follow-up schedules after treatment for malignant melanoma. Br J Surg 2008;95:1401-7. [PMID: 18844268 DOI: 10.1002/bjs.6347] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
183 Foiato TF, Bereza BRK, Montenegro MF, Guilherme MR, Volski LB, Rebolho JC. Analysis of patients diagnosed with primary cutaneous melanoma in the last six years in Hospital Erasto Gaertner: epidemiologic profile. An Bras Dermatol 2018;93:332-6. [PMID: 29924232 DOI: 10.1590/abd1806-4841.20185788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
184 Aloia TA, Gershenwald JE. Management of early-stage cutaneous melanoma. Curr Probl Surg 2005;42:460-534. [PMID: 16099230 DOI: 10.1067/j.cpsurg.2005.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
185 van der Ploeg AP, van Akkooi AC, Verhoef C, Eggermont AM. Completion lymph node dissection after a positive sentinel node: no longer a must? Curr Opin Oncol. 2013;25:152-159. [PMID: 23328628 DOI: 10.1097/cco.0b013e32835dafb4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 2.6] [Reference Citation Analysis]
186 Sabattini S, Kiupel M, Finotello R, Stefanello D, Faroni E, Bertazzolo W, Bonfanti U, Rigillo A, Del Magno S, Foglia A, Aresu L, Gambini M, Caniatti M, Marconato L. A retrospective study on prophylactic regional lymphadenectomy versus nodal observation only in the management of dogs with stage I, completely resected, low-grade cutaneous mast cell tumors. BMC Vet Res 2021;17:331. [PMID: 34649575 DOI: 10.1186/s12917-021-03043-0] [Reference Citation Analysis]
187 Schmalbach CE, Bradford CR. Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma. Laryngoscope Investig Otolaryngol 2018;3:43-8. [PMID: 29492467 DOI: 10.1002/lio2.136] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
188 Lloyd MS, Topping A, Allan R, Powell B. Contraindications to sentinel lymph node biopsy in cutaneous malignant melanoma. Br J Plast Surg 2004;57:725-7. [PMID: 15544768 DOI: 10.1016/j.bjps.2003.12.028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
189 Yee VS, Thompson JF, Mckinnon JG, Scolyer RA, Li LL, Mccarthy WH, O’brien CJ, Quinn MJ, Saw RP, Shannon KF, Stretch JR, Uren RF. Outcome in 846 Cutaneous Melanoma Patients From a Single Center After a Negative Sentinel Node Biopsy. Ann Surg Oncol 2005;12:429-39. [DOI: 10.1245/aso.2005.03.074] [Cited by in Crossref: 101] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
190 Jing G, Wu Y, Song H, Ren G, Wang R, Guo W. Primary Malignant Melanoma of the Lip: A Report of 48 Cases. J Oral Maxillofac Surg 2015;73:2232-40. [PMID: 26047711 DOI: 10.1016/j.joms.2015.05.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
191 Pawlik TM, Sondak VK. Malignant melanoma: current state of primary and adjuvant treatment. Critical Reviews in Oncology/Hematology 2003;45:245-64. [DOI: 10.1016/s1040-8428(02)00080-x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
192 Sherman KL, Kinnier CV, Farina DA, Wayne JD, Laskin WB, Agulnik M, Attar S, Hayes JP, Peabody T, Bilimoria KY. Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma: Sarcoma Nodal Evaluation. J Surg Oncol 2014;110:682-8. [DOI: 10.1002/jso.23687] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
193 Kirkwood JM, Jukic DM, Averbook BJ, Sender LS. Melanoma in pediatric, adolescent, and young adult patients. Semin Oncol 2009;36:419-31. [PMID: 19835737 DOI: 10.1053/j.seminoncol.2009.07.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.0] [Reference Citation Analysis]
194 Ross MI, Thompson JF, Gershenwald JE. Sentinel Lymph Node Biopsy for Melanoma: Critical Assessment at its Twentieth Anniversary. Surgical Oncology Clinics of North America 2011;20:57-78. [DOI: 10.1016/j.soc.2010.10.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
195 Eggermont AM. European approach to the treatment of malignant melanoma: . Current Opinion in Oncology 2002;14:205-11. [DOI: 10.1097/00001622-200203000-00011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
196 Eggermont AM, Voit C. Management of Melanoma: A European Perspective. Surgical Oncology Clinics of North America 2008;17:635-48. [DOI: 10.1016/j.soc.2008.02.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
197 Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients. Eur J Surg Oncol 2008;34:82-8. [PMID: 17360144 DOI: 10.1016/j.ejso.2007.01.027] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.2] [Reference Citation Analysis]
198 Leitao MM Jr. Management of vulvar and vaginal melanomas: current and future strategies. Am Soc Clin Oncol Educ Book 2014;:e277-81. [PMID: 24857113 DOI: 10.14694/EdBook_AM.2014.34.e277] [Cited by in Crossref: 29] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
199 van Akkooi ACJ, Bouwhuis MG, de Wilt JHW, Kliffen M, Schmitz PIM, Eggermont AMM. Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma. British Journal of Surgery 2007;94:1293-9. [DOI: 10.1002/bjs.5814] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
200 Santinami M, Maurichi A, Patuzzo R, Pennacchioli E, Cascinelli N. Impact of Clinical Trials on the Treatment of Melanoma. Surgical Oncology Clinics of North America 2001;10:935-47. [DOI: 10.1016/s1055-3207(18)30040-1] [Cited by in Crossref: 11] [Article Influence: 0.6] [Reference Citation Analysis]
201 Platt S, Coleridge S, Hughes G, Donkers H, Wiggans A, Frost J, Rolland P, Julian S, Morrison J, Pawade J, Patel A, Newton C. Management of Malignant Vulval Melanoma: A Retrospective Case Series and Review of the Literature. J Low Genit Tract Dis 2020;24:272-6. [PMID: 32205765 DOI: 10.1097/LGT.0000000000000521] [Reference Citation Analysis]
202 Cho SI, Lee J, Jo G, Kim SW, Minn KW, Hong KY, Jo SJ, Cho KH, Kim BJ, Mun JH. Local recurrence and metastasis in patients with malignant melanomas after surgery: A single-center analysis of 202 patients in South Korea. PLoS One 2019;14:e0213475. [PMID: 30845184 DOI: 10.1371/journal.pone.0213475] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
203 Fife K, Thompson JF. Lymph-node metastases in patients with melanoma: what is the optimum management? The Lancet Oncology 2001;2:614-21. [DOI: 10.1016/s1470-2045(01)00519-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Habashi R, Francescutti V. Nonsurgical Management of Lymph Node Basins in Melanoma. Surg Clin North Am 2020;100:91-107. [PMID: 31753118 DOI: 10.1016/j.suc.2019.09.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
205 Balch C, Soong S, Thompson J. The natural history of melanoma and factors predicting outcome. In: Thompson J, Morton D, Kroon B, editors. Textbook of Melanoma. CRC Press; 2003. pp. 181-98. [DOI: 10.1201/b14732-16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
206 Perone JA, Farrow N, Tyler DS, Beasley GM. Contemporary Approaches to In-Transit Melanoma. J Oncol Pract 2018;14:292-300. [PMID: 29746804 DOI: 10.1200/JOP.18.00063] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
207 Schmalbach CE, Johnson TM, Bradford CR. The management of head and neck melanoma. Curr Probl Surg 2006;43:781-835. [PMID: 17112819 DOI: 10.1067/j.cpsurg.2006.08.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
208 Medalie N, Ackerman A. Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now. Br J Dermatol 2004;151:298-307. [DOI: 10.1111/j.1365-2133.2004.06132.x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
209 Balch CM, Soong S, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, Mcmasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu P, Lyman GH, Morabito A. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System. JCO 2001;19:3622-34. [DOI: 10.1200/jco.2001.19.16.3622] [Cited by in Crossref: 1728] [Cited by in F6Publishing: 397] [Article Influence: 86.4] [Reference Citation Analysis]
210 Faries MB, Han D, Reintgen M, Kerivan L, Reintgen D, Caracò C. Lymph node metastasis in melanoma: a debate on the significance of nodal metastases, conditional survival analysis and clinical trials. Clin Exp Metastasis 2018;35:431-42. [PMID: 29777421 DOI: 10.1007/s10585-018-9898-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
211 Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012;32:1363-1372. [PMID: 22466491 DOI: 10.1097/iae.0b013e31824d09a8] [Cited by in Crossref: 125] [Cited by in F6Publishing: 51] [Article Influence: 13.9] [Reference Citation Analysis]
212 Peixoto IC, Sousa JM. Clinical and biological aspects of sentinel node biopsy in malignant melanoma — an update. Clin Transl Oncol 2005;7:145-9. [DOI: 10.1007/bf02708751] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
213 Ross MI, Gershenwald JE. Sentinel lymph node biopsy for melanoma: A critical update for dermatologists after two decades of experience. Clinics in Dermatology 2013;31:298-310. [DOI: 10.1016/j.clindermatol.2012.08.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
214 Lange JR. The Current Status of Sentinel Node Biopsy in the Management of Melanoma: . Dermatologic Surgery 2000;26:809-10. [DOI: 10.1046/j.1524-4725.2000.00157.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
215 Riker AI, Kirksey L, Thompson L, Morris A, Cruse CW. Current surgical management of melanoma. Expert Rev Anticancer Ther 2006;6:1569-83. [PMID: 17134362 DOI: 10.1586/14737140.6.11.1569] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
216 Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol 2004;11:162S-8S. [PMID: 15023745 DOI: 10.1007/BF02523622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 0.1] [Reference Citation Analysis]
217 Zenga J, Nussenbaum B, Cornelius LA, Linette GP, Desai SC. Management Controversies in Head and Neck Melanoma: A Systematic Review. JAMA Facial Plast Surg 2017;19:53-62. [DOI: 10.1001/jamafacial.2016.1038] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
218 Kruijff S, Vink R, Klaase J. Salvage surgery for a giant melanoma on the back. Rare Tumors 2011;3:e28. [PMID: 22066035 DOI: 10.4081/rt.2011.e28] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
219 Young SE, Martinez SR, Faries MB, Essner R, Wanek LA, Morton DL. Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes? Cancer J 2006;12:207-11. [PMID: 16803679 DOI: 10.1097/00130404-200605000-00009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
220 Sabel MS, Griffith K, Sondak VK, Lowe L, Schwartz JL, Cimmino VM, Chang AE, Rees RS, Bradford CR, Johnson TM. Predictors of Nonsentinel Lymph Node Positivity in Patients with a Positive Sentinel Node for Melanoma. Journal of the American College of Surgeons 2005;201:37-47. [DOI: 10.1016/j.jamcollsurg.2005.03.029] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 6.9] [Reference Citation Analysis]
221 Lang PG. Current concepts in the management of patients with melanoma. Am J Clin Dermatol 2002;3:401-26. [PMID: 12113649 DOI: 10.2165/00128071-200203060-00004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
222 Koopal S, Tiebosch A, Daryanani D, Plukker J, Hoekstra H. Extra nodal growth as a prognostic factor in malignant melanoma. European Journal of Surgical Oncology (EJSO) 2005;31:88-94. [DOI: 10.1016/j.ejso.2004.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
223 Sondak VK, Ross MI, Schuchter LM. Early stage (I, II, III) melanoma. Curr Treat Options Oncol 2001;2:183-91. [PMID: 12057118 DOI: 10.1007/s11864-001-0032-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
224 Pharis DB. Cutaneous melanoma: therapeutic lymph node and elective lymph node dissections, lymphatic mapping, and sentinel lymph node biopsy. Dermatol Ther 2005;18:397-406. [PMID: 16297015 DOI: 10.1111/j.1529-8019.2005.00046.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
225 Teltzrow T, Osinga J, Schwipper V. Reliability of sentinel lymph-node extirpation as a diagnostic method for malignant melanoma of the head and neck region. International Journal of Oral and Maxillofacial Surgery 2007;36:481-7. [DOI: 10.1016/j.ijom.2007.02.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
226 Leiter U, Buettner PG, Eigentler TK, Garbe C. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. J Clin Oncol 2004;22:3660-7. [PMID: 15302905 DOI: 10.1200/JCO.2004.03.074] [Cited by in Crossref: 83] [Cited by in F6Publishing: 11] [Article Influence: 4.9] [Reference Citation Analysis]
227 Lamboo LGE, Haydu LE, Scolyer RA, Quinn MJ, Saw RPM, Shannon KF, Spillane AJ, Stretch JR, Bonenkamp JJ, Thompson JF. The Optimum Excision Margin and Regional Node Management for Primary Cutaneous T3 Melanomas (2–4 mm in Thickness): A Retrospective Study of 1587 Patients Treated at a Single Center. Annals of Surgery 2014;260:1095-102. [DOI: 10.1097/sla.0000000000000792] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
228 Robsahm TE, Helsing P, Nilssen Y, Vos L, Rizvi SMH, Akslen LA, Veierød MB. High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registry. Clin Epidemiol 2018;10:537-48. [PMID: 29780262 DOI: 10.2147/CLEP.S151246] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 5.7] [Reference Citation Analysis]
229 Hantschke M, Bastian BC, LeBoit PE. Consumption of the epidermis: a diagnostic criterion for the differential diagnosis of melanoma and Spitz nevus. Am J Surg Pathol 2004;28:1621-5. [PMID: 15577682 DOI: 10.1097/00000478-200412000-00011] [Cited by in Crossref: 53] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
230 McMasters KM, Noyes RD, Reintgen DS, Goydos JS, Beitsch PD, Davidson BS, Sussman JJ, Gershenwald JE, Ross MI. Lessons learned from the Sunbelt Melanoma Trial. J Surg Oncol. 2004;86:212-223. [PMID: 15221928 DOI: 10.1002/jso.20084] [Cited by in Crossref: 175] [Cited by in F6Publishing: 135] [Article Influence: 10.3] [Reference Citation Analysis]
231 Pandalai PK, Dominguez FJ, Michaelson J, Tanabe KK. Clinical Value of Radiographic Staging in Patients Diagnosed With AJCC Stage III Melanoma. Ann Surg Oncol 2011;18:506-13. [DOI: 10.1245/s10434-010-1272-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
232 Gad D, Høilund-carlsen PF, Bartram P, Clemmensen O, Bischoff-mikkelsen M. Staging patients with cutaneous malignant melanoma by same-day lymphoscintigraphy and sentinel lymph node biopsy: A single-institutional experience with emphasis on recurrence. J Surg Oncol 2006;94:94-100. [DOI: 10.1002/jso.20433] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
233 Hewitt DB, Merkow RP, Delancey JO, Wayne JD, Hyngstrom JR, Russell MC, Gerami P, Balch CM, Bilimoria KY. National practice patterns of completion lymph node dissection for sentinel node-positive melanoma: HEWITT et al.. J Surg Oncol. [DOI: 10.1002/jso.25160] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
234 Bedrosian I, Gershenwald JE. Surgical clinical trials in melanoma. Surgical Clinics of North America 2003;83:385-403. [DOI: 10.1016/s0039-6109(02)00099-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
235 Chang JM, Kosiorek HE, Dueck AC, Leong SPL, Vetto JT, White RL, Avisar E, Sondak VK, Messina JL, Zager JS, Garberoglio C, Kashani-Sabet M, Pockaj BA. Stratifying SLN incidence in intermediate thickness melanoma patients. Am J Surg 2018;215:699-706. [PMID: 29502857 DOI: 10.1016/j.amjsurg.2017.12.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
236 Estourgie SH, Nieweg OE, Vald�s Olmos RA, Hoefnagel CA, Kroon BBR. Review and Evaluation of Sentinel Node Procedures in 250 Melanoma Patients With a Median Follow-Up of 6 Years. Ann Surg Oncol 2003;10:681-8. [DOI: 10.1245/aso.2003.01.023] [Cited by in Crossref: 112] [Cited by in F6Publishing: 11] [Article Influence: 6.2] [Reference Citation Analysis]
237 Urist MM. Melanoma and sentinel nodes. Current Surgery 2003;60:16-20. [DOI: 10.1016/s0149-7944(02)00756-0] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
238 Tanis PJ, Nieweg OE, van den Brekel MWM, Balm AJM. Dilemma of clinically node-negative head and neck melanoma: Outcome of “watch and wait” policy, elective lymph node dissection, and sentinel node biopsy—A systematic review. Head Neck 2008;30:380-9. [DOI: 10.1002/hed.20749] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
239 Ding S, Soong SJ, Lin HY, Desmond R, Balch CM. Parametric modeling of localized melanoma prognosis and outcome. J Biopharm Stat 2009;19:732-47. [PMID: 20183437 DOI: 10.1080/10543400902964175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
240 Zgajnar J, Hocevar M, Podkrajsek M, Hertl K, Frkovic-Grazio S, Vidmar G, Besic N. Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients. Breast Cancer Res Treat 2006;97:293-9. [PMID: 16333526 DOI: 10.1007/s10549-005-9123-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
241 Bradbury MS, Pauliah M, Zanzonico P, Wiesner U, Patel S. Intraoperative mapping of sentinel lymph node metastases using a clinically translated ultrasmall silica nanoparticle. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2016;8:535-53. [PMID: 26663853 DOI: 10.1002/wnan.1380] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
242 Badgwell B, Xing Y, Gershenwald JE, Lee JE, Mansfield PF, Ross MI, Cormier JN. Pelvic Lymph Node Dissection Is Beneficial in Subsets of Patients with Node-positive Melanoma. Ann Surg Oncol 2007;14:2867-75. [DOI: 10.1245/s10434-007-9512-7] [Cited by in Crossref: 48] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
243 Mcmasters KM, Wong SL, Edwards MJ, Chao C, Ross MI, Noyes RD, Viar V, Cerrito PB, Reintgen DS; Sunbelt Melanoma Trial Group. Frequency of nonsentinel lymph node metastasis in melanoma. Annals of Surgical Oncology 2002;9:137-41. [DOI: 10.1007/bf02557364] [Cited by in Crossref: 108] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
244 Reintgen D, Pendas S, Jakub J, Swor G, Giuliano R, Bauer J, Cassall R, Duhaime L, Alsarrai M, Shivers S. National trials involving lymphatic mapping for melanoma: the multicenter selective lymphadenectomy trial, the sunbelt melanoma trial, and the florida melanoma trial. Seminars in Oncology 2004;31:363-73. [DOI: 10.1053/j.seminoncol.2004.03.017] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
245 Testori A, Rutkowski P, Marsden J, Bastholt L, Chiarion-Sileni V, Hauschild A, Eggermont AM. Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol 2009;20 Suppl 6:vi22-9. [PMID: 19617294 DOI: 10.1093/annonc/mdp257] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 5.7] [Reference Citation Analysis]
246 Fortes C, Mastroeni S, Caggiati A, Passarelli F, Zappalà A, Capuano M, Bono R, Nudo M, Marino C, Michelozzi P. The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival. The American Journal of Surgery 2016;212:935-40. [DOI: 10.1016/j.amjsurg.2016.02.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
247 Schuitevoerder D, Grinlington L, Stevens J, Nance R, Fortino J, Vetto JT. Nonvisualized sentinel lymph nodes on lymphoscintigraphy in melanoma: predictive factors and surgical outcomes. Nuclear Medicine Communications 2017;38:383-7. [DOI: 10.1097/mnm.0000000000000658] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
248 Wargo JA, Tanabe K. Surgical management of melanoma. Hematol Oncol Clin North Am 2009;23:565-81, x. [PMID: 19464603 DOI: 10.1016/j.hoc.2009.03.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
249 Landry CS, Mcmasters KM, Scoggins CR. The evolution of the management of regional lymph nodes in melanoma: Management of Regional Lymph Nodes in Melanoma. J Surg Oncol 2007;96:316-21. [DOI: 10.1002/jso.20867] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
250 Eedy D. Surgical treatment of melanoma. Br J Dermatol 2003;149:2-12. [DOI: 10.1046/j.1365-2133.149.s64.8_65.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
251 Boland GM, Gershenwald JE. Sentinel Lymph Node Biopsy in Melanoma. The Cancer Journal 2012;18:185-91. [DOI: 10.1097/ppo.0b013e31825046c7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
252 Roulin D, Matter M, Bady P, Liénard D, Gugerli O, Boubaker A, Bron L, Lejeune F. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution. European Journal of Surgical Oncology (EJSO) 2008;34:673-9. [DOI: 10.1016/j.ejso.2007.07.197] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
253 Bagaria SP, Faries MB, Morton DL. Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute. J Surg Oncol 2010;101:669-76. [PMID: 20512942 DOI: 10.1002/jso.21581] [Cited by in Crossref: 50] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
254 Kimbrough CW, McMasters KM, Davis EG. Principles of surgical treatment of malignant melanoma. Surg Clin North Am 2014;94:973-88, vii. [PMID: 25245962 DOI: 10.1016/j.suc.2014.07.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
255 van Akkooi AC, Atkins MB, Agarwala SS, Lorigan P. Surgical Management and Adjuvant Therapy for High-Risk and Metastatic Melanoma. Am Soc Clin Oncol Educ Book 2016;35:e505-14. [PMID: 27249760 DOI: 10.1200/EDBK_159087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
256 de Braud F, Khayat D, Kroon BB, Valdagni R, Bruzzi P, Cascinelli N. Malignant melanoma. Crit Rev Oncol Hematol 2003;47:35-63. [PMID: 12853098 DOI: 10.1016/s1040-8428(02)00077-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
257 Hayes AJ, Maynard L, Coombes G, Newton-Bishop J, Timmons M, Cook M, Theaker J, Bliss JM, Thomas JM; UK Melanoma Study Group., British Association of Plastic., Reconstructive and Aesthetic Surgeons, and the Scottish Cancer Therapy Network. Wide versus narrow excision margins for high-risk, primary cutaneous melanomas: long-term follow-up of survival in a randomised trial. Lancet Oncol 2016;17:184-92. [PMID: 26790922 DOI: 10.1016/S1470-2045(15)00482-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 18] [Article Influence: 15.2] [Reference Citation Analysis]
258 Piñero A, de Torre C, Martínez-escribano J, Campillo J, Canteras M, Nicolás F. Multiple Lymphatic Basin Drainage from Cutaneous Melanoma as a Prognostic Factor. World J Surg 2012;36:579-85. [DOI: 10.1007/s00268-011-1402-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
259 Kingham TP, Karakousis G, Ariyan C. Randomized clinical trials in melanoma. Surg Oncol Clin N Am 2010;19:13-31. [PMID: 19914558 DOI: 10.1016/j.soc.2009.09.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
260 Smith VA, Cunningham JE, Lentsch EJ. Completion Node Dissection in Patients with Sentinel Node–Positive Melanoma of the Head and Neck. Otolaryngol Head Neck Surg 2012;146:591-9. [DOI: 10.1177/0194599811432672] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
261 Madu M, Wouters M, van Akkooi A. Sentinel node biopsy in melanoma: Current controversies addressed. European Journal of Surgical Oncology (EJSO) 2017;43:517-33. [DOI: 10.1016/j.ejso.2016.08.007] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
262 Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma: 2010 update. Journal of the American Academy of Dermatology 2010;62:723-34. [DOI: 10.1016/j.jaad.2009.11.695] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
263 Doben AR, MacGillivray DC. Current concepts in cutaneous melanoma: malignant melanoma. Surg Clin North Am 2009;89:713-25. [PMID: 19465207 DOI: 10.1016/j.suc.2009.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
264 Wernick BD, Goel N, Zih FS, Farma JM. A surgical perspective report on melanoma management. Melanoma Manag 2017;4:105-12. [PMID: 30190913 DOI: 10.2217/mmt-2016-0031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
265 Thompson JF, Scolyer RA, Kefford RF. Cutaneous melanoma. The Lancet 2005;365:687-701. [DOI: 10.1016/s0140-6736(05)17951-3] [Cited by in Crossref: 174] [Cited by in F6Publishing: 107] [Article Influence: 10.9] [Reference Citation Analysis]
266 St Peter SD, Roarke MC, Conley CR, Pockaj BA. Sentinel lymph node biopsy demonstrating concomitant melanoma and mantle cell lymphoma. Surgery 2002;131:216-8. [PMID: 11854704 DOI: 10.1067/msy.2002.115355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
267 Herrmann M, Bloch E, Overbeck T, Koerber W, Wolff H, Hille A, Vorwerk H, Hess C, Muller M, Christiansen H, Pradier O. Mediastinal radiotherapy after multidrug chemotherapy and prophylactic cranial irradiation in patients with SCLC – treatment results after long-term follow-up and literature overview. Cancer/Radiothérapie 2011;15:81-8. [DOI: 10.1016/j.canrad.2010.03.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
268 Blazer DG, Sondak VK, Sabel MS. Surgical Therapy of Cutaneous Melanoma. Seminars in Oncology 2007;34:270-80. [DOI: 10.1053/j.seminoncol.2007.03.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
269 Leong SP. Selective sentinel lymphadenectomy for malignant melanoma, Merkel cell carcinoma, and squamous cell carcinoma. Cancer Treat Res 2005;127:39-76. [PMID: 16209077 DOI: 10.1007/0-387-23604-x_3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
270 Dessureault S, Soong SJ, Ross MI, Thompson JF, Kirkwood JM, Gershenwald JE, Coit DG, McMasters KM, Balch CM, Reintgen D; American Joint Committee on Cancer (AJCC) Melanoma Staging Committee. Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol 2001;8:766-70. [PMID: 11776489 DOI: 10.1007/s10434-001-0766-1] [Cited by in Crossref: 88] [Cited by in F6Publishing: 65] [Article Influence: 4.6] [Reference Citation Analysis]
271 Depasquale I, Thompson WD. Microvessel density for melanoma prognosis. Histopathology 2005;47:186-94. [DOI: 10.1111/j.1365-2559.2005.02193.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
272 Elder DE, Gimotty PA, Guerry D. Cutaneous melanoma: estimating survival and recurrence risk based on histopathologic features. Dermatol Ther 2005;18:369-85. [DOI: 10.1111/j.1529-8019.2005.00044.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
273 Eggermont AM, Gore M. European approach to adjuvant treatment of intermediate- and high-risk malignant melanoma. Seminars in Oncology 2002;29:382-8. [DOI: 10.1053/sonc.2002.34117] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
274 Fritsch VA, Cunningham JE, Lentsch EJ. Completion Lymph Node Dissection Based on Risk of Nonsentinel Metastasis in Cutaneous Melanoma of the Head and Neck. Otolaryngol Head Neck Surg 2016;154:94-103. [DOI: 10.1177/0194599815605494] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
275 Eggermont AM. Randomized Trials in Melanoma: An Update. Surgical Oncology Clinics of North America 2006;15:439-51. [DOI: 10.1016/j.soc.2005.12.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
276 Chan AD, Essner R, Wanek LA, Morton DL. Judging the therapeutic value of lymph node dissections for melanoma>21>No competing interests declared.22Supported by NIH grant PO NCI CA 29605 and by funding from the Wrather Family Foundation, Los Angeles, CA. Dr Essner is a recipient of an American Cancer Society Career Development Award. Journal of the American College of Surgeons 2000;191:16-22. [DOI: 10.1016/s1072-7515(00)00313-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 2] [Article Influence: 1.9] [Reference Citation Analysis]
277 Allard-Coutu A, Heller B, Francescutti V. Surgical Management of Lymph Nodes in Melanoma. Surg Clin North Am 2020;100:71-90. [PMID: 31753117 DOI: 10.1016/j.suc.2019.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
278 McMasters KM, Reintgen DS, Ross MI, Gershenwald JE, Edwards MJ, Sober A, Fenske N, Glass F, Balch CM, Coit DG. Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol 2001;19:2851-5. [PMID: 11387357 DOI: 10.1200/JCO.2001.19.11.2851] [Cited by in Crossref: 161] [Cited by in F6Publishing: 13] [Article Influence: 8.1] [Reference Citation Analysis]
279 Bogenrieder T, van Dijk MR, Blokx WAM, Ramrath K, Seldenrijk K, Stolz W, van Diest PJ. No non-sentinel node involvement in melanoma patients with limited Breslow thickness and low sentinel node tumour load: Identifying melanoma patients with no sentinel node involvement. Histopathology 2011;59:318-26. [DOI: 10.1111/j.1365-2559.2011.03931.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
280 Bartlett EK. Current management of regional lymph nodes in patients with melanoma. J Surg Oncol 2019;119:200-7. [PMID: 30481384 DOI: 10.1002/jso.25316] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]